Search

Katherine G Rendahl

from Berkeley, CA
Age ~63
Get Report
Also known as:
Katherine Gates Rendahl, Katherine Te Rendahl, Katherine C Rendahl, Katherine G Rendhl, Katherine L
Phone and address:
1221 Grizzly Peak Blvd, Berkeley, CA 94708
(510) 848-1812
Related to:
Sandra I Rendahl, 90Justin Rendahl, 46Gerald D Rendahl, 91Justin Rendahl, 55Margery Rendahl, 88
Connected to:
Jonathan Rendak, 38Janimarie A Rendal, 64Adam J Rendall, 41Alison M Rendall, 73Clark Rendall, 41Elizabeth A Rendall, 68Jane H Rendall, 97Karla A Rendall, 48Kathleen J Rendall, 76Kristen B Rendall, 50

Katherine Rendahl Phones & Addresses

  • 1221 Grizzly Peak Blvd, Berkeley, CA 94708 (510) 848-1812
  • Wellesley, MA
  • Waltham, MA
  • Bolton, MA
  • Cambridge, MA
  • 1221 Grizzly Peak Blvd, Berkeley, CA 94708 (510) 928-0177

Work

Position: Professional/Technical

Education

Degree: Graduate or professional degree

Publications

Us Patents

Use Of Recombinant Gene Delivery Vectors For Treating Or Preventing Diseases Of The Eye

View page
US Patent:
20020194630, Dec 19, 2002
Filed:
Mar 4, 2002
Appl. No.:
10/090983
Inventors:
William Manning - Redwood City CA, US
Varavani Dwarki - Pittstown NJ, US
Katherine Rendahl - Berkeley CA, US
Shangzhen Zhou - Alameda CA, US
Laura McGee - Oakland CA, US
Dana Lau - Oakland CA, US
John Flannery - Berkeley CA, US
Sheldon Miller - Berkeley CA, US
Fei Wang - Albany CA, US
Adriana Di Polo - Outremont, CA
International Classification:
A61K048/00
A01K067/00
US Classification:
800/008000, 514/044000
Abstract:
Gene delivery vectors, such as, for example, recombinant adeno-associated viral vectors, and methods of using such vectors are provided for use in treating or preventing diseases of the eye.

Treatment Of Melanoma

View page
US Patent:
20100086518, Apr 8, 2010
Filed:
Mar 7, 2008
Appl. No.:
12/530231
Inventors:
Carla C. Heise - Benicia CA, US
Paul Hollenbach - Castro Valley CA, US
Daniel Menezes - Emeryville CA, US
Nancy Pryer - Kensington CA, US
Katherine Rendahl - Berkeley CA, US
Marion Wiesmann - Brisbane CA, US
Assignee:
NOVARTIS AG - Basel
International Classification:
A61K 31/496
A61P 35/00
A61K 33/24
A61K 31/655
A61K 31/662
A61K 38/12
A61K 38/20
A61K 38/21
US Classification:
424 852, 51425307, 424649, 514151, 514115, 514 9, 424 854, 424 857
Abstract:
Methods of treating melanoma include administering a compound of Structure I, a tautomer of the compound, a pharmaceutically acceptable salt of the compound, a pharmaceutically acceptable salt or the tautomer, or a mixture thereof to a subject. The compound, tautomer, salt of the compound, salt of the tautomer, or mixture thereof may be used to prepare medicaments for treating metastatic cancer. The variable A has the values defined herein.

Use Of Recombinant Gene Delivery Vectors For Treating Or Preventing Diseases Of The Eye

View page
US Patent:
6943153, Sep 13, 2005
Filed:
Sep 20, 2000
Appl. No.:
09/665493
Inventors:
Varavani J. Dwarki - Pittstown NJ, US
Katherine Rendahl - Berkeley CA, US
Shangzhen Zhou - Alameda CA, US
Sheldon S. Miller - Berkeley CA, US
Fei Wang - Albany CA, US
Assignee:
The Regents of the University of California - Oakland CA
Chiron Corporation - Emeryville CA
International Classification:
A01N043/04
A01N063/00
A61K031/70
A61K048/00
A61K039/23
A61K039/235
US Classification:
514 44, 424 9321, 4242331
Abstract:
Gene delivery vectors, such as, for example, recombinant adeno-associated viral vectors, and methods of using such vectors are provided for use in treating or preventing diseases of the eye.

Antibody Drug Conjugates

View page
US Patent:
20190194315, Jun 27, 2019
Filed:
Jun 17, 2016
Appl. No.:
15/737042
Inventors:
Tinya ABRAMS - Acton MA, US
Steven Bruce COHEN - San Diego CA, US
Joseph Anthony D'Alessio - Boston MA, US
Jason Damiano - Oakland CA, US
Clemens Durr - Weil am Rhein, DE
Bernhard Hubert GEIERSTANGER - Solana Beach CA, US
Thomas HUBER - Basel, CH
Hidetomo IMASE - Somerville MA, US
Yunho JIN - San Diego CA, US
Daniel MENEZES - Berkeley CA, US
Kathy MILLER - San Francisco CA, US
Morvarid MOHSENI - Boston MA, US
Weijia OU - San Diego CA, US
Katherine RENDAHL - Berkeley CA, US
Tetsuo UNO - San Diego CA, US
Yongqin WAN - San Diego CA, US
Xing WANG - San Diego CA, US
Assignee:
Novartis AG - Basel
International Classification:
C07K 16/28
A61K 47/65
A61K 47/68
A61P 35/00
A61K 38/07
Abstract:
This application discloses anti-P-cadherin antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments, particularly antibody drug conjugates comprising anti-P-cadherin antibodies conjugated to auristatin analogs. The invention also relates to methods of treating cancer using the antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.

Antibody Drug Conjugates

View page
US Patent:
20160137730, May 19, 2016
Filed:
Nov 13, 2015
Appl. No.:
14/940961
Inventors:
Tinya ABRAMS - Acton MA, US
Steven Bruce Cohen - San Diego CA, US
Jason Damiano - Oakland CA, US
Clemens Dürr - Weil am Rhein, DE
Thomas Huber - Allschwil, CH
Daniel Menezes - Berkeley CA, US
Kathy Miller - San Francisco CA, US
Katherine Rendahl - Berkeley CA, US
Jean-Michel Rene Rondeau - Rixheim, FR
Assignee:
Novartis AG - Basel
International Classification:
C07K 16/28
G01N 33/574
A61K 47/48
C07K 16/30
A61K 31/5365
Abstract:
This application discloses anti-P-cadherin antibodies, antigen binding fragments thereof, and antibody drug conjugates of said antibodies or antigen binding fragments. The invention also relates to methods of treating cancer using the antibodies, antigen binding fragments, and antibody drug conjugates. Also disclosed herein are methods of making the antibodies, antigen binding fragments, and antibody drug conjugates, and methods of using the antibodies and antigen binding fragments as diagnostic reagents.
Control profile
Katherine G Rendahl from Berkeley, CA, age ~63 Get Report